Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Sex and Gender-Based Differences in Engagement and Outcomes among Participants in Injectable and Tablet Injectable Opioid Agonist Treatment (iOAT / TiOAT) - A Cohort Analysis
EF 2025-26
Résumé
The opioid crisis is an urgent public health emergency in Canada, with women increasingly experiencing disproportionate harms, such as exposure to gender-based violence, and additional obstacles to receiving addiction treatment, such as caregiving demands and economic barriers. For those experiencing treatment-refractory opioid use disorder, iOAT is an evidence-based intervention that offers pharmaceutical-grade opioids, usually injectable hydromorphone or diacetylmorphine, under supervision. On the other hand, TiOAT, which is administered within the same model of care as iOAT, has surfaced as a pharmaceutical substitute for the toxic, unregulated drug supply for individuals who are most at risk of overdosing, and entails the supervised consumption of tablet hydromorphone. However, most iOAT and TiOAT assessments have not employed a sex and gender-based analysis lens, instead relying on collected information that conceals gender-specific risk and recovery patterns. Although emerging qualitative work has examined women’s experiences in iOAT programs, there is currently no quantitative evidence comparing the needs, treatment paths, or outcome-oriented metrics of men and women in iOAT/TiOAT models. Our ability to create gender-responsive iOAT/TiOAT services, which may be crucial for enhancing results for women and gender-diverse people, is hampered by this knowledge gap. The proposed research aims to identify sex-and gender-based differences in clinical, demographic, and social characteristics of people accessing iOAT/TiOAT services in British Columbia, and to determine the impact of sex/gender on retention, adherence, and recovery outcomes among individuals receiving iOAT and TiOAT.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
573173
Name
Amjad Maryam
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Sex and Gender-Based Differences in Engagement and Outcomes among Participants in Injectable and Tablet Injectable Opioid Agonist Treatment (iOAT / TiOAT) - A Cohort Analysis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Gender; Health; Ioat; Opiods; Sex; Substance Use; Tioat
Abstract
The opioid crisis is an urgent public health emergency in Canada, with women increasingly experiencing disproportionate harms, such as exposure to gender-based violence, and additional obstacles to receiving addiction treatment, such as caregiving demands and economic barriers. For those experiencing treatment-refractory opioid use disorder, iOAT is an evidence-based intervention that offers pharmaceutical-grade opioids, usually injectable hydromorphone or diacetylmorphine, under supervision. On the other hand, TiOAT, which is administered within the same model of care as iOAT, has surfaced as a pharmaceutical substitute for the toxic, unregulated drug supply for individuals who are most at risk of overdosing, and entails the supervised consumption of tablet hydromorphone. However, most iOAT and TiOAT assessments have not employed a sex and gender-based analysis lens, instead relying on collected information that conceals gender-specific risk and recovery patterns. Although emerging qualitative work has examined women’s experiences in iOAT programs, there is currently no quantitative evidence comparing the needs, treatment paths, or outcome-oriented metrics of men and women in iOAT/TiOAT models. Our ability to create gender-responsive iOAT/TiOAT services, which may be crucial for enhancing results for women and gender-diverse people, is hampered by this knowledge gap. The proposed research aims to identify sex-and gender-based differences in clinical, demographic, and social characteristics of people accessing iOAT/TiOAT services in British Columbia, and to determine the impact of sex/gender on retention, adherence, and recovery outcomes among individuals receiving iOAT and TiOAT.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Amjad, Maryam
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~